Patel Sanj Kinsider trades
In SEC Form 4 filings, Patel Sanj K is listed as CHAIRMAN & CEO of Kiniksa Pharmaceuticals International, plc (KNSA). Patel Sanj K reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 3.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| KNSAKiniksa Pharmaceuticals International, plc | CHAIRMAN & CEO | 22 | Sep 3 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M | 9,991 | not reported | not reported | 86,165 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M | 6,481 | not reported | not reported | 92,646 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M | 6,237 | not reported | not reported | 98,883 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M | 8,609 | not reported | not reported | 107,492 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | F | 15,144 | $79.28 | $1,200,616 | 92,348 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | A · derivative | 30,050 | $0.00 | $0 | 30,050 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | A · derivative | 120,150 | $79.28 | $9,525,492 | 120,150 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M · derivative | 8,609 | $0.00 | $0 | 25,826 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M · derivative | 6,237 | $0.00 | $0 | 12,475 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M · derivative | 6,481 | $0.00 | $0 | 6,481 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M · derivative | 9,991 | $0.00 | $0 | not reported | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M | 9,991 | not reported | not reported | 86,165 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M | 6,481 | not reported | not reported | 92,646 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M | 6,237 | not reported | not reported | 98,883 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M | 8,609 | not reported | not reported | 107,492 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | F | 15,144 | $79.28 | $1,200,616 | 92,348 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | A · derivative | 30,050 | $0.00 | $0 | 30,050 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | A · derivative | 120,150 | $79.28 | $9,525,492 | 120,150 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M · derivative | 8,609 | $0.00 | $0 | 25,826 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M · derivative | 6,237 | $0.00 | $0 | 12,475 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M · derivative | 6,481 | $0.00 | $0 | 6,481 | No | Form 4 |
| KNSAKiniksa Pharmaceuticals International, plc | Sep 1 | Sep 3 | M · derivative | 9,991 | $0.00 | $0 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.